Orexo AB: Interim Report, January-March 2013  
4/26/2013 6:33:24 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Orexo (STO:ORX)

Unless otherwise stated in this report, all data refers to the Group. Figures in parentheses relate to the corresponding period in 2012.

The transition to a commercial and profitable pharmaceutical company continues

During the period

•Net revenues amounted to MSEK 139.8 (83.6).

Help employers find you! Check out all the jobs and post your resume.